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ABSTRACT
Mycobacterium tuberculosis remains one of the most problematic
infectious agents, owing to its highly developed mechanisms to
evade host immune responses combined with the increasing
emergence of antibiotic resistance. Host-directed therapies aiming
to optimize immune responses to improve bacterial eradication or to
limit excessive inflammation are a new strategy for the treatment of
tuberculosis. In this study, we have established a zebrafish-
Mycobacterium marinum natural host-pathogen model system to
study induced protective immune responses in mycobacterial
infection. We show that priming adult zebrafish with heat-killed
Listeria monocytogenes (HKLm) at 1 day prior to M. marinum
infection leads to significantly decreased mycobacterial loads in the
infected zebrafish. Using rag1−/− fish, we show that the protective
immunity conferred by HKLm priming can be induced through innate
immunity alone. At 24 h post-infection, HKLm priming leads to a
significant increase in the expression levels of macrophage-
expressed gene 1 (mpeg1), tumor necrosis factor α (tnfa) and nitric
oxide synthase 2b (nos2b), whereas superoxide dismutase 2 (sod2)
expression is downregulated, implying that HKLm priming increases
the number of macrophages and boosts intracellular killing
mechanisms. The protective effects of HKLm are abolished when
the injected material is pretreated with nucleases or proteinase
K. Importantly, HKLm priming significantly increases the frequency of
clearance of M. marinum infection by evoking sterilizing immunity
(25 vs 3.7%,P=0.0021). In this study, immune priming is successfully
used to induce sterilizing immunity against mycobacterial infection.
This model provides a promising new platform for elucidating the
mechanisms underlying sterilizing immunity and to develop host-
directed treatment or prevention strategies against tuberculosis.
This article has an associated First Person interview with the first
author of the paper.
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INTRODUCTION
Tuberculosis (TB) is an airborne respiratory disease caused by the
intracellular bacterium Mycobacterium tuberculosis (Mtb). As few
as one to five bacteria can lead to an infection (Rajaram et al., 2014;
Cambier et al., 2014). The outcome of TB is highly variable,
ranging from rapid clearance by innate immune mechanisms to
development of active disease or the formation of a latent infection
that can be actively contained inside granulomas but not eradicated.
According to Centers for Disease Control and Prevention (CDC)
estimates, even one third of the world population is infected with
Mtb. However, only 5-10% of this population develops active,
primary TB. Commonly, infection with Mtb leads to a latent,
asymptomatic disease with the inherent ability to reactivate and
disseminate into an active disease even decades after initial
exposure, for example in the case of immunosuppression. In
2015, 1.4 million people died of TB and a total of 10.4 million new
cases were reported along with an increasing number of multidrug-
resistant strains (World Health Organization, 2016; http://www.
who.int/tb/publications/2016/en/). Despite available multidrug
therapies and the Bacille Calmette–Guérin (BCG) vaccine, TB
remains one of the leading infectious killers worldwide. According
to a recent study, the standard 6-month antibiotic treatment against
TB is ineffective in the eradication of Mtb even in patients with a
successful follow through of the antibiotic treatment (Malherbe
et al., 2016). As the current preventive and treatment strategies have
proven insufficient, new approaches to control the global TB
epidemic are urgently needed. Host-directed therapies offer a
promising approach to improve the outcome of anti-TB treatments.
Host-directed therapies are a form of adjunctive therapy that aim to
modulate the host immune responses to eradicate or limit
mycobacterial infection (Tobin, 2015).
Mycobacteria are especially successful in evading immune
responses. Macrophages are known to limit mycobacterial growth
in early infection to some extent (Clay et al., 2007). However,
in many cases, the early events of mycobacterial infections are
characterized by bacterial dominance. Pathogenic mycobacteria are
able to avoid recognition by pattern-recognition receptors and
can lure mycobacterium-permissive macrophages to the sites of
infection (Cambier et al., 2014). Upon phagocytosis, they block the
fusion of phagosomes with lysosomes (Russell, 2011), translocateReceived 7 August 2017; Accepted 21 November 2017
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to the cytoplasm (Simeone et al., 2012; Houben et al., 2012) and
neutralize nitric oxide (NO) species (Flynn and Chan, 2003),
allowing them to survive within macrophages. Astonishingly,
mycobacteria are even capable of exploiting macrophages for tissue
dissemination (Clay et al., 2007). In addition to avoiding innate
killing mechanisms, mycobacteria also inhibit transportation of
mycobacterial antigens to lymph nodes (Wolf et al., 2008; Reiley
et al., 2008; Gallegos et al., 2008), thereby hampering the initiation
of adaptive responses (Chackerian et al., 2002). Aggregates of
innate and adaptive immune cells, called granulomas, are formed to
contain the bacteria and to localize the infection to a limited area
without eradicating the bacteria. Depending on the immune status of
the host, either an active infection or a latent infection with a life-
long risk of reactivation ensues (Barry et al., 2009).
Despite Mtb being good at evading host immune responses and
having the ability to cause aggressive active or persistent latent
infections, some people are known to be naturally protected against
TB. There are significant differences in the ability of individuals to
resist mycobacterial infection, reflecting the heterogenic nature of the
human population. According to epidemiological data, a 7-43%
proportion of heavily exposed individuals are able to clear the infection
before the onset of adaptive immunity, resulting in negative tuberculin
skin tests and interferon-gamma (Ifnγ) release assays (reviewed in
Verrall et al., 2014).With this in mind, it should be possible to shift the
balance of host-pathogen interactions in favor of the host by directing
the immune response to the right immune activation at the early stages
of infection, when the bacterial loads are rather small. Optimal immune
activation could prevent mycobacterial evasion strategies, enhance
killing of mycobacteria and ideally lead to sterilization of infection.
However, to our knowledge, sterilizing antimycobacterial immunity
has not been successfully induced in vivo.
In this study, we used the zebrafish model to study protective
immune responses against mycobacteria at the early stages of
infection. The zebrafish has recently become a well-accepted
genetically tractable vertebrate model for human TB pathogenesis.
Zebrafish are naturally susceptible to Mycobacterium marinum, a
close genetic relative of Mtb. M. marinum causes a disease that
shares the main pathological and histological features of human TB,
including the formation of macrophage aggregates and granulomas
(reviewed in Meijer, 2016; van Leeuwen et al., 2014). As the basic
mechanisms of innate and adaptive immunity are conserved from
zebrafish to humans, the innate immune responses to M. marinum
can be studied in zebrafish larvae (Ramakrishnan, 2013), while the
adult zebrafish has been proven an applicable model to study also
the adaptive responses in TB (Hammarén et al., 2014; Parikka et al.,
2012; Oksanen et al., 2013). Even the transition of an acute primary
infection to latency and its reactivation can be modeled in the adult
zebrafish (Parikka et al., 2012), which has been difficult in other
models. Our previous studies have shown that an infection with a
low dose ofM. marinum causes a latent mycobacterial disease with
steady bacterial counts in the majority of the fish population,
whereas, in a small proportion of the fish (<1.5%), primary active
disease leads to mortality (Parikka et al., 2012). Around 10% of the
fish are able to clear the mycobacterial infection (Hammarén et al.,
2014). The spectrum of different disease outcomes in the
M. marinum-zebrafish model thus resembles that of human TB.
Here, we have used the zebrafish model to test whether the number
of individuals sterilizing the infection can be increased through
injection with different priming agents to circumvent mycobacterial
virulence strategies, which generally lead to persistent, latent
infections (Parikka et al., 2012). Our study shows that the priming
of zebrafish with heat-killed Listeria monocytogenes results in the
sterilization ofM.marinum infection in one fourth of individuals. The
protective effect is caused by a protein and/or nucleic acid component
of L. monocytogenes and is accompanied by the induction of tumor
necrosis factor α (tnfα) and nitric oxide synthase 2b (nos2b), and
downregulation of superoxide dismutase 2 (sod2). Hereby, we show
that the adult zebrafish is a feasible model for deciphering the
mechanisms of sterilizing immunity, knowledge of which is crucial
for the development of new preventive strategies and adjunctive
therapies against TB.
RESULTS
Immune activation by heat-killed L. monocytogenes leads to
lower mycobacterial burdens in adult zebrafish
In this study, we set out to investigate protective immune responses
at the early stages of anM.marinum infection. Our hypothesis is that
the right immune activation at the early stages of an infection
prevents mycobacterial evasion strategies and leads to protective
immune responses, increased killing of mycobacteria or even
clearing of mycobacteria. To study our hypothesis, we wanted to
direct the zebrafish immune response towards an optimal anti-TB
response before the onset of an M. marinum infection. To find a
factor that promotes a protective immune response in the early
stages of an infection in adult zebrafish, fish were intraperitoneally
(i.p.) injected with different priming agents 1 day before a low-dose
i.p. M. marinum infection (Fig. 1A,B). Mycobacterial loads of the
fish were determined with quantitative real-time PCR (qPCR) from
internal organs at 7 weeks post-infection (wpi). We tested eight
different agents, including Toll-like receptor (TLR) ligands, vaccine
adjuvants and heat-killed bacteria, namely: heat-killedM. marinum
(HKMm), L. monocytogenes (HKLm), Streptococcus iniae (HKSi)
and Escherichia coli (HKEc), lipopolysaccharide (LPS), paclitaxel,
muramyl dipeptide (MDP) and zymosan.
In this preliminary experiment, the tested priming agents had
variable effects onmycobacterial loads. Priming of the adult fish with
HKLm led to a clear decrease in median mycobacterial loads at 7 wpi
compared to phosphate-buffered saline (PBS) controls. However,
with most of the other tested priming agents, including HKMm, the
reduction in mycobacterial loads was not as dramatic as with HKLm
(Fig. 1B). Importantly, HKLm priming was the most efficient way to
induce bacterial clearance. The frequency of clearance increased by
4.8-fold compared to PBS-primed controls. For paclitaxel, priming
led to an increase in mycobacterial loads. With the right dosing,
paclitaxel can induce proinflammatory responses (Bracci et al., 2014)
but can also be toxic to immune cells (Tang et al., 2017), whichmight
explain the increase in mycobacterial load by paclitaxel. Our results
indicate that early immune priming affects mycobacterial loads at 7
wpi and that HKLm is the most promising priming agent with our
experimental setup.
To ensure that the reduction in mycobacterial loads in adult fish
was not due to direct bactericidal effects of HKLm priming, we
incubated M. marinum in 7H9 medium together with different
concentrations of HKLm (Fig. S1). Based on in vitro culturing,
HKLm does not kill M. marinum, indicating that the lowered
mycobacterial burdens in zebrafish induced by HKLm priming is
not due to direct killing of the mycobacteria by HKLm, but is
mediated through effects on the host immune system.
To characterize the duration of the effect after HKLm priming, we
injected fish at either 1 or 7 days prior to infection withM. marinum.
The mycobacterial loads were determined already at 4 wpi because,
at this stage of the infection, bacterial counts have generally reached
a steady state and they are easily measurable. Priming 1 day prior to
infection was most efficient, increasing the frequency of a clearing
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response by 3.7-fold compared to the control group (7 days: 2.3-
fold) in this preliminary experiment (Fig. 1C). Based on these
results, we continued with HKLm priming at 1 day before M.
marinum infection.
Priming with HKLm increases the frequency of clearance of
mycobacterial infection in adult zebrafish
To verify our finding from the preliminary priming experiments,
zebrafish were primed with an injection of HKLm (Fig. 2A) 1 day prior
to M. marinum infection, and PBS was used as a negative control.
Compared to control treatments, priming with HKLm 1 day before
infection consistently led to a significant decrease (14.1-fold decrease,
on average) in mycobacterial loads in adult zebrafish at 4 wpi (Fig. 2A
shows a representative result of four separate experiments).
From our previous study, we know that, without priming,
approximately 10% of M. marinum-infected zebrafish are able to
naturally clear the mycobacterial infection (Hammarén et al., 2014).
Combining the results from four different experiments shows that
priming with HKLm 1 day prior toM. marinum infection increases
the frequency of sterilizing response by 6.8-fold in the wild-type
fish at 4 wpi [PBS 3.7% (n=54) vs HKLm 25% (n=56), P=0.0021]
(Fig. 2B). However, individuals that have been unable to clear the
infection also benefit from HKLm priming in terms of lowered
bacterial loads (Fig. S2). In a wild-type population with sustained
infection, HKLm reduced the median bacterial load by 11.1-fold
(P<0.0001).
Innate immune mechanisms mediate HKLm-induced
protection against mycobacterial infection
Our results show a beneficial effect of HKLm priming on
mycobacterial loads and clearance at 7 wpi (Fig. 1B) and 4 wpi
(Fig. 2A), as well as at 2 wpi (Fig. 2C), all of which are late enough
stages for both innate and adaptive responses to be active, although
it is known that virulent mycobacteria cause a delay in the activation
of T-cell responses (Gallegos et al., 2008). To test whether HKLm
priming has the same reducing effect on mycobacterial loads in the
absence of an adaptive immune response, we used rag1−/− mutant
fish. Fish lacking rag1 do not undergo V(D)J recombination, which
is essential for the production of the full variety of T- and B-cell
receptors. The rag1−/− mutants therefore rely solely on their innate
immune mechanisms for protection against infections (Wienholds
et al., 2002).
When rag1−/− mutants were primed with HKLm 1 day beforeM.
marinum infection and bacterial loads were measured with qPCR at
4 wpi, HKLm priming caused a similar reduction in bacterial loads
in rag1−/− mutants (30-fold, P=0.0089) as in wild-type fish (9.7-
fold, P=0.0013) (Fig. 2D,A). Also in rag1−/− mutants, priming
with HKLm increased the frequency of sterilizing response from 0%
(n=26) to 17% (n=23) (P=0.0418) (Fig. 2E). Looking at the fish
with a sustained infection (unable to clear the infection), HKLm
priming reduced the bacterial load in rag1mutants by 7.2-fold (Fig.
S2B, not statistically significant). HKLm priming did not affect the
cumulative mortality of low-dose-infected wild-type adult fish
Fig. 1. The effect of priming agents on M. marinum loads in adult zebrafish. (A) Outline of the study. Adult wild-type zebrafish were primed with 0.5×107-
1×107 colony-forming units (cfu) per fish of heat-killed bacteria or with other priming agents (13.5 µg per fish, except MDP 4.5 µg) 1 or 7 days prior toM. marinum
infection (−1/7 day) with an i.p. injection. Sterile 1× PBSwas used as an injection control. The following day (0 day), a low dose ofM.marinumwas injected i.p. into
the zebrafish. Internal organs were collected either 2, 4 or 7 weeks post infection (wpi), DNA was extracted and the bacterial counts were measured with M.
marinum-specific qPCR. (B) Priming with heat-killed L. monocytogenes (HKLm) reduces mycobacterial loads at 7 wpi. Zebrafish were primed with either PBS
(n=8), heat-killed M. marinum (HKMm; n=9), HKLm (n=10), heat-killed S. iniae (HKSi; n=8), heat-killed E. coli (KHEc; n=9), lipopolysaccharide (LPS; n=8),
paclitaxel (n=5), muramyl dipeptide (MDP; n=9) or zymosan (n=10) 1 day prior to M. marinum infection (16±4 cfu). Organs were collected at 7 wpi. Priming with
HKLm led to a bigger decrease in the mycobacterial loads in adult zebrafish compared to other tested priming agents. Paclitaxel increased the mycobacterial
loads in adult zebrafish. Medians are shown in the figure. (C) Priming with HKLm 1 day prior toM.marinum infection increases the frequency of clearance. The fold
change in the percentage of fish that were able to clear the M. marinum infection was higher in the group that was primed with HKLm 1 day prior (3.7-fold; PBS:
n=12, HKLm: n=13) to infection compared to group that was primed 7 days (2.3-fold; PBS: n=12, HKLm: n=12) before the infection.
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(PBS: 11.7%; HKLm: 11.2%) but caused a trend of reduced
mortality in rag1−/− mutant fish (PBS: 24.5%; HKLm: 11.1%)
(Fig. 2F,G). Together, these results imply an important role for
innate immunity in the formation of protective HKLm-induced
immune responses against mycobacterial infection. Importantly,
they show that an optimal response induced by HKLm priming
significantly increases the frequency of clearance of mycobacterial
infection also in the absence of adaptive immunity.
Protective effects of HKLm priming are not seen in the larval
M. marinum-infection model
As our results showed that the protective effects of HKLm priming
can be mediated through innate immune responses alone, we next
used zebrafish larvae to test the effect of HKLm priming on M.
marinum infection. During the first weeks of development,
zebrafish lack adaptive immune responses and rely solely on
innate immune responses, making it possible to study mechanisms
of mycobacterial infection that arise from innate immunity. To this
end, zebrafish larvaewere primed with HKLm to induce a protective
immune response against M. marinum infection. Zebrafish were
primed by intravenous injection either at 1 day post-fertilization
(dpf ) (Fig. S3A) or at 2 dpf (Fig. S3B). M. marinum infection was
carried out intravenously at 2 dpf. Within this experimental setting,
mycobacterial loads were not reduced in zebrafish larvae after
priming with HKLm (Fig. S3), possibly due to the immaturity of
immune responses in the young larvae or due to the relatively lower
HKLm dose that could be delivered into the larvae. As we were
unable to see any protective effect in the zebrafish larvae, we
continued using adult zebrafish for subsequent experiments.
Protective immunity against M. marinum infection is
mediated by a protein and/or nucleic acid component of
HKLm
Based on the results of the preliminary experiment with different
priming agents, HKLm seemed to contain a specific component
responsible for the induction of sterilizing immunity. To characterize
Fig. 2. Priming with HKLm significantly reduces mycobacterial loads in adult zebrafish via innate responses. (A) Priming of adult zebrafish with
0.5×107 cfu of HKLm 1 day prior to M. marinum infection (27±2 cfu) led to a significant decrease in mycobacterial loads compared to control injection of sterile
1× PBS. The graph shows one representative experiment. Samples were collected at 4 wpi (PBS: n=19, HKLm: n=19). (B) Priming with HKLm 1 day prior to
M. marinum infection leads to sterilization ofM. marinum in 25% of the wild-type (WT) zebrafish. Clearance percentage in the WT PBS control group was 3.7%.
The data were collected from four independent experiments. M. marinum infection doses in the independent experiments were 27±2 cfu, 26±13 cfu, 75±13 cfu
and 26±8 cfu. PBS: n=54, HKLm: n=56. (C) Priming of adult zebrafish with HKLm leads to a significant decrease inmycobacterial loads compared to PBS controls
already at 2 wpi. Infection dose: 48±8 cfu. PBS: n=11, HKLm: n=12. (D) HKLm priming 1 day prior to M. marinum infection significantly reduced mycobacterial
loads in rag1−/−mutant fish compared to the PBS control group at 4 wpi, indicating a role for innate immune responses. The graph contains a combined result from
two separate experiments. M. marinum infection doses were 48±8 cfu and 27±2 cfu. (E) Priming with HKLm 1 day prior to M. marinum infection leads to
sterilization of M. marinum in 17% of the rag1−/− mutant fish. Clearance percentage in the PBS control group was 0%. Data are pooled from two independent
experiments. PBS: n=26, HKLm: n=23. (F,G) HKLm priming did not affect cumulativemortality inWTadult fish (F; PBS: n=152, HKLm: n=170), but caused a trend
of reduced mortality in HKLm-injected rag1−/− mutant fish (PBS: n=53, HKLm: n=55). P-values in A, C and D were calculated with a two-tailed non-parametric
Mann–Whitney test with GraphPad Prism. Medians for the individual experiments are shown in the figures. The P-values in B, E, F and G were calculated with
Fisher’s test using GraphPad (QuickCalcs) online software.
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the protective component(s), we carried out a set of experiments in
which zebrafish were primed with different preparations of HKLm
1 day prior to M. marinum infection and bacterial growth was
analyzed at 4 wpi. Priming with spent L. monocytogenesmedium did
not cause a significant reduction in themycobacterial loads of the fish,
indicating that a secreted factorwas not the causative agent behind the
activation of antimycobacterial immune responses (Fig. 3A).We also
found that, after autoclavation of L. monocytogenes, priming with the
insoluble material provided a protective effect against M. marinum
infection, whereas the soluble material was not protective (Fig. 3B).
However, we were able to show that treatment of the HKLm extract
with either proteinase K or a cocktail of RNase and DNase abolished
the protective effect (Fig. 3C). These results indicate that the
protective component is stable, resistant to high temperature and
pressure, non-secreted, insoluble, and likely consists of both a protein
and nucleic acid component.
Therapeutic potential of HKLm treatment
To further characterize the features of HKLm treatment, a 30-fold
higher HKLm dose was injected 1 day prior to low-dose M.
marinum infection. With such a high dose, HKLm lost its beneficial
effects (Fig. 4A) and there was a trend of increased mortality of the
fish by 4 wpi (PBS: 22.7%; HKLm: 41.7%) (Fig. 4B). According to
these results, it was concluded that, by increasing the HKLm dose, it
is not possible to further boost the protective effect but rather
vice versa. The optimal dosage thus plays a crucial role in inducing a
protective response.
We then tested whether priming with HKLm 1 day prior to
infection could protect fish against a high-dose infection challenge
with 4883±919 colony-forming units (cfu) of M. marinum. In the
context of a high-dose infection, HKLm did not induce significant
difference in the mycobacterial loads, clearance or cumulative
end-point mortality at 4 wpi (Fig. 4C,D).
We next wanted to test whether HKLm can induce protective
immune responses if themycobacterial infection is alreadyestablished.
We have previously shown in adult zebrafish that, at 2 wpi, M.
marinum infection is well established and granulomas have already
started to form (Parikka et al., 2012).We infected adult zebrafishwith a
low dose of M. marinum, injected HKLm at 2 wpi and measured
mycobacterial loads, as well as determined the cumulative mortality at
4 wpi. Based on our results, at a time point in which the mycobacteria
have already multiplied substantially and started forming granulomas,
HKLm injection was not able to lower the bacterial loads, increase
bacterial clearance or affect cumulative mortality (Fig. 4E,F).
Priming adult zebrafish with HKLm inducesmpeg1, tnfα and
nos2expression, anddownregulates sod2, at theearly phase
of mycobacterial infection
We were interested in further characterizing the nature of the
immune response induced by HKLm priming in adult zebrafish. We
hypothesized that the protective effect could be mediated through
enhanced killing of mycobacteria at the early phase of the infection
due to changes in the numbers or activity of innate immune cells. To
study the details of HKLm-induced immune activation by qPCR,
the fish were primed with HKLm or PBS, infected with a low dose
ofM. marinum 1 day after priming and the total RNAwas extracted
from zebrafish organs collected 1 day post-infection (dpi). First, the
possible effects of HKLm treatment on the number of macrophages
and neutrophils were assessed by measuring the expression of
macrophage expressed gene 1 (mpeg1) (Ellett et al., 2011) and
myeloid-specific peroxidase (mpx) (Lieschke et al., 2001),
respectively. In the HKLm group, mpeg1 expression was
significantly higher than in the control group (Fig. 5A; HKLm:
59.9-fold; PBS: 39.3-fold; P=0.0352), suggesting that the number
of macrophages was increased due to HKLm priming. The
expression of mpx was not affected by HKLm (Fig. 5B).
Fig. 3. Protective immunity against
M. marinum is mediated by a protein
and/or nucleic acid component of
HKLm. (A-C) Zebrafish were primed
with different components of HKLm and
L. monocytogenes 1 day prior to M.
marinum infection and mycobacterial
loads were determined with M.
marinum-specific qPCR at 4 wpi.
(A) Protective immunity is not mediated
by a secreted component in the L.
monocytogenes growth medium.
Infection dose: 26±6 cfu; PBS: n=10,
medium: n=16. (B) Protective immunity
is mediated by a component that was
found in the insoluble phase. Infection
dose: 33±11 cfu; PBS: n=10, insoluble:
n=12, soluble: n=12. (C) Protective
effect of HKLm priming was lost when
HKLm was treated with DNase and
RNase, or proteinase K. Infection dose:
33±11 cfu; PBS: n=10, DNase and
RNase: n=7, proteinase K: n=8. P-
values for all experiments were
calculated with a two-tailed non-
parametric Mann–Whitney test with
GraphPad Prism and corrected with the
Bonferroni’s method. Medians for each
experiment are shown.
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To assess the HKLm-induced changes at the level of immune cell
activation, we measured the expression of a selection of markers
related to the effective antimycobacterial functions of innate
immune cells 1 day after M. marinum infection. Based on
literature on the mechanisms limiting intracellular mycobacterial
growth, the genes chosen for analysis were tnfα (Cobat et al., 2015;
Roca and Ramakrishnan, 2013), ifnγ (Flynn et al., 1993) and nos2b
(Nicholson et al., 1996; Thoma-Uszynski et al., 2001). Expression
of ifnγ was not differentially induced between PBS- and HKLm-
treated groups (Fig. 5C,D). The median expression levels of tnfα
(Fig. 5F; HKLm 10.3-fold vs PBS 1.1-fold, P=0.0043) and nos2b
(Fig. 5G; HKLm 10.7-fold vs 0.6-fold PBS, P=0.0001) were
significantly increased in the HKLm-primed group compared to the
PBS control group. We also analyzed the expression levels of sod2,
which encodes a mitochondrial protein that converts the
byproducts of oxidative phosphorylation to hydrogen peroxide
and oxygen, leading to neutralization of mitochondrial reactive
oxygen species (ROS) (Pias et al., 2003) and arg1, which is an
alternative macrophage activation marker (Gordon and Martinez,
2010). In the HKLm group, sod2 expression was significantly
more downregulated as compared to the PBS group, indicating
increased levels of ROS due to HKLm priming (PBS 0.59-fold
vs HKLm 0.27-fold, P=0.0022) (Fig. 5H). Arg1, however, was
not induced in HKLm-primed fish, suggesting that alternative
activation does not have an impact on the early mycobacterial
elimination (Fig. 5E). Together, these results suggest that
HKLm induces M1-type classical macrophage activation
leading to enhanced intracellular killing at the early stages of a
mycobacterial infection.
Priming of macrophages with HKLm leads to decreased
oxygen consumption in vitro
Classically activated M1 macrophages have been shown to change
their metabolism upon immune activation (Cheng et al., 2014). To
test whether this is also the case with HKLm priming, we set up a
RAW264.7 cell culture and primed them either with LPS (50 ng/µl)
or HKLm (MOI: 530). At 19-24 h later, oxygen consumed by these
cells was measured using a Clark electrode. We used LPS as a
positive control and showed that both treatments lower the oxygen
consumption significantly (Fig. 5I). Pooled result from three
independent experiments concluded that HKLm- or LPS-primed
mouse macrophages consume, respectively, 1.8-times (P=0.008)
and 2.3-times (P=0.0042) less oxygen compared to untreated cells,
in vitro (Fig. 5I). This result implies that HKLm-treated
macrophages exhibit metabolic changes indicative of diminished
oxygen similar to those observed during classical macrophage
activation.
DISCUSSION
Despite substantial progress in the field of medicine, TB still kills
millions of people every year and has been declared a global public
health crisis (World Health Organization, 2016; http://www.who.
int/tb/publications/2016/en/). The advances in the battle against TB
have been hindered by the complex nature of the disease and the
limitations of tuberculosis animal models. TB manifests itself in a
wide spectrum of disease, with most affected individuals being
unable to eradicate the causative bacteria (Mtb), leading to the
development of latent TB infection, which has a lifetime risk of
reactivation in 5-10% of cases. The World Health Organization has
Fig. 4. HKLm treatment does not protect against
high-dose or established M. marinum infection.
(A,B) Protective effect of HKLm priming is lost with
high-dose priming. Fish were injected with a high dose
of HKLm (15.6×107 cfu, 30-fold compared to previous
dose) 1 day prior to M. marinum infection (34±11 cfu).
Priming with a high dose of HKLm did not reduce
mycobacterial numbers (A) and led to an increase in
the mortality of the fish at 4 wpi (B). PBS: n=10, HKLm:
n=10. (C,D) HKLm priming does not protect from high-
dose M. marinum infection. Fish were primed with
HKLm 1 day prior to high-dose M. marinum infection
(4883±919 cfu). No effect was observed on bacterial
loads (C) or cumulative end-point mortality (D). PBS:
n=16, HKLm: n=17. (E,F) HKLm does not protect
against an establishedM. marinum infection. Fish were
injected with HKLm 2 weeks after an M. marinum
infection (22±6 cfu). No effect on mycobacterial loads
(E) or cumulative end-point mortality (F) was observed.
PBS: n=14, HKLm: n=16. P-values for bacterial loads
were calculated with a two-tailed non-parametric
Mann–Whitney test with GraphPad Prism (A,C,E).
Medians for the experiments are shown.
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estimated that 2-3 billion people are latently infected with Mtb
(World Health Organization, 2016), creating a huge pool of
individuals with a potential to develop an active, transmissive
disease. As current vaccination and antibiotic schemes have proven
insufficient for controlling the global TB epidemic, host-directed
therapies inducing protective immune responses are emerging as a
novel strategy to treat TB (Tobin, 2015). Efficient host-directed
therapies used either alone or in combination with antibiotics are an
approach that could potentially lead to sterilization of TB.
Although genome-wide association studies carried out in humans
have given important clues on the nature of protective immune
responses against TB (Azad et al., 2012; Wilkinson et al., 2000;
Cobat et al., 2009, 2015), animal models are essential for the
execution of more mechanistic studies. The mouse, rabbit and
macaque have been widely used to study TB (Myllymäki et al.,
2015). To the best of our knowledge, spontaneous or induced
sterilizing immunity has not been observed at the organismal level
in mammalian animal models of TB. Clearance of cultivable
mycobacteria occurs in the rabbit model (Subbian et al., 2012).
However, standard bacterial culturing methods only detect the
actively replicating mycobacterial populations, but not dormant
bacteria (Chao and Rubin, 2010), and, in the rabbit, the clearance of
cultivable mycobacteria indicates the establishment of a truly latent
disease instead of sterilization (Subbian et al., 2012). The zebrafish
has recently become a well-accepted genetically tractable vertebrate
model for human TB pathogenesis to complement the more
traditional mammalian models (Myllymäki et al., 2015). In our
previous study, using a qPCR-based method, we were able to see
spontaneous clearance of mycobacterial infection in the zebrafish-
M. marinum infection model in approximately 10% of the fish at 4
wpi (Hammarén et al., 2014). As we observed no clearance at 2 wpi
(Hammarén et al., 2014), spontaneous early clearance (likely
induced by innate mechanisms) in our wild-type zebrafish
population is a rare event. In this current study, we were able to
increase the frequency of sterilizing mycobacterial infection by
priming the innate immune response prior toM. marinum infection.
Our hypothesis was that priming or stimulation of the immune
response in the adult zebrafish before M. marinum infection could
lead to a sterilizing immune response instead of a lethal primary
active disease or a latent infection that is prone to reactivation later in
life (Parikka et al., 2012). By using an array of different priming
agents, we wanted to study whether we could create a climate that
would allow the immune response to circumvent their efficient
virulence strategies and even eradicate the mycobacteria. Priming
approaches have been successful in inducing protective responses
against various other bacterial infections in the fruit fly, Drosophila
melanogaster, which relies solely on innate immunity (Pham et al.,
2007). Indeed, our results showed that sterilizing immunity can be
induced in the M. marinum zebrafish model. In our hands, priming
with HKLm induces a sterilizing response in 25% of M. marinum-
Fig. 5. HKLm priming induces mpeg, tnfα and nos2b expression, downregulates sod2 expression in adult zebrafish and leads to decreased oxygen
consumption in vitro. (A-H) The expression levels of mpeg (A), mpx (B), ifnγ1-1 (C), ifnγ1-2 (D), arg1 (E), tnfα (F), nos2b (G) and sod2 (H) were measured
with qPCR from wild-type fish primed with HKLm or sterile PBS buffer as a control. At 1 day after the priming, the fish were infected with a low dose (67±16 cfu)
of M. marinum. Samples for qPCR analysis were collected at 1 dpi. The results were normalized to uninfected wild-type baseline control. PBS: n=10, HKLm:
n=11. (I) HKLm priming leads to metabolic changes in vitro. RAW264.7 cells were primed with LPS or HKLm and oxygen consumption was measured 19-24 h
after priming. HKLm priming leads to a 1.8-fold decrease (P=0.008) in oxygen consumption compared to control. LPS was used as a positive control
(2.3-fold decrease, P=0.0042). PBS: n=9, LPS: n=7, HKLm: n=9. P-values for all experiments were calculated with a two-tailed non-parametric Mann–Whitney
test with GraphPad Prism. Medians for each experiment are shown. Bonferroni correction was used in C.
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infected fish at 4 wpi, whereas the percentage of spontaneous
clearance was 3.7% in the PBS-primed control group.
The M. marinum-specific qPCR used to quantify bacterial loads
is a sensitive method, with a detection limit of approximately 100
bacterial genomes in the entire fish (Parikka et al., 2012; Hammarén
et al., 2014). The major advantage of a qPCR-based method over
culturing methods is that qPCR detects all bacterial genomes
irrespective of metabolic state so that dormant bacteria are also
detected. An advantage of the zebrafish is that, due to its small size,
all infection target organs can be collected for determination of
bacterial load, which is not practically feasible in larger animals.
Based on the qPCR results, we are able to say that 25% of the wild-
type fish were able to clear the infection, indicating that HKLm
priming indeed increases the frequency of sterilizing immune
response. This model provides tools for elucidating the detailed
mechanisms behind sterilizing immunity against TB.
To study whether the protective effects of HKLm priming require
a functional adaptive immune system, we used rag1 mutant
zebrafish. Although rag1 mutant zebrafish are known to be
hypersusceptible to M. marinum infection due to a failure in the
development of functional T and B cells (Swaim et al., 2006;
Parikka et al., 2012), their bacterial loads were significantly lowered
and even cleared by HKLm priming, suggesting that the protective
response can be mediated by innate immunity alone. The role of
innate immunity is also supported by the significant HKLm-
induced reduction in bacterial loads as early as 2 wpi in wild-type
fish, by which time adaptive responses are only starting to arise in
mycobacterial infections (Andersen and Woodworth, 2014).
Despite the clear involvement of innate responses in HKLm-
induced protective responses in adult fish, the results could not be
reproduced in young zebrafish larvae that have only innate
immunity, probably due to an immature immune response and
technical difficulties to deliver high enough doses of HKLm by
microinjection methods. As adaptive responses are centrally
involved in the pathogenesis of mycobacterial infections, using
the adult zebrafish will likely better model the effects of
immunomodulatory treatments on the immune response as a
whole. On top of the protective effects of HKLm mediated
through innate immunity, an additional level of protection was
observed in the presence of a functional adaptive immune system in
zebrafish. However, the observation that activation of innate
immunity alone by immune priming with HKLm in some cases
was sufficient for induction of a protective or sterilizing immunity
opens new avenues for host-directed therapies or preventive
strategies even in the absence of a fully functional adaptive
immune system, such as in patients with an HIV co-infection.
At the moment, there is no immunotherapy that could cure an
ongoing mycobacterial infection by simply boosting the immune
system. Therefore, wewanted to study whether HKLm could induce
a protective response during an established mycobacterial infection.
A single dose of HKLm was injected 2 weeks after M. marinum
infection, when early granulomas have started to form and are
visible in various organs (Parikka et al., 2012). However, this single
injection of HKLm did not decrease mycobacterial loads at 4 wpi
(Fig. 4E,F). By this time point, M. marinum has already had plenty
of time to exert its early virulence strategies leading to effective
avoidance of the pro-inflammatory host immune response (Elks
et al., 2014; Queval et al., 2016; Bhat et al., 2017; Cambier et al.,
2014). Having gained a foothold within its host, mycobacteria are
not as prone to the effects caused by a single therapeutic injection of
HKLm as they are when entering a primed host. Adult zebrafish
have also been used to model active fulminant TB by infecting
individuals with a high M. marinum dose (Parikka et al., 2012).
Individuals infected with a high M. marinum dose did not benefit
from HKLm priming. The high infection dose of a few thousand
mycobacteria leads to a disease state in which the capacity of the
immune system rapidly becomes saturated, allowing the bacteria to
grow almost logarithmically (Parikka et al., 2012) possibly due to
the limited number of macrophages (Pagán et al., 2015) compared to
the low infection dose; a situation too challenging to overcome even
in the presence of HKLm priming. However, in our preliminary
experiments, we saw that, in addition to priming 1 day prior to
infection, protective effects were still visible when HKLm priming
was delivered 1 week prior to M. marinum infection (Fig. 1C),
suggesting that this type of protective response could be considered
in designing new preventive strategies.
The protective effects of HKLm treatment delivered prior to
infection could be mediated through the induction of trained
immunity. It is known that innate immune cells can mediate an
enhanced immune response upon reinfection with the same
pathogen (Quintin et al., 2012). The innate immune system can
also cross-react with a new pathogen according to previous stimuli
(Kleinnijenhuis et al., 2014). It has been reported that some vaccines
can produce durable cross-protection that cannot be explained by
adaptive responses (Aaby et al., 2014). This type of nonspecific
innate memory is referred to as trained immunity. Mechanisms of
trained immunity have also been shown to be responsible for BCG-
induced by-stander protection against Candida albicans in the
mouse (Van’t Wout et al., 1992). Innate memory is mediated
through reversible epigenetic changes rather than irreversible
genetic recombination seen during the formation of classical
immunological memory in adaptive immune cells and can last for
weeks to months (reviewed by Netea et al., 2016). The effects of
trained immunity in the context of susceptibility to TB is an
interesting area of research and can yield new approaches in the
development of preventive strategies based on innate immunity.
It has been reported that the number of macrophages is critical for
the disease outcome and that macrophage deficiency is connected to
accelerated progression of mycobacterial infection (Pagán et al.,
2015). To assess the effect of HKLm priming on the number of
macrophages and neutrophils, we measured the expression of the
commonly used markers mpeg1 (Ellett et al., 2011) and mpx
(Lieschke et al., 2001), respectively. Based on the expression of
these markers, the number of macrophages was significantly higher
in HKLm-primed fish (P=0.0352), whereas the amount of
neutrophils remained unchanged (Fig. 5A,B). This change seen in
macrophages is potentially mediating the protective response
against mycobacteria.
To decipher the type of protective immune response induced by
HKLm priming, we measured an array of genes related to innate
immune activation in the organs ofM. marinum-infected zebrafish at
1 dpi. In line with in vitro studies on Listeria (Barbuddhe et al., 1998;
Mirkovitch et al., 2006), in vivo priming with HKLm caused a
significant increase in nos2b and tnfαwith a simultaneous decrease in
sod2 expression. nos2b is one of the NO synthases in zebrafish
(Lepiller et al., 2009). NO is known to be mycobacteriocidal
(Nicholson et al., 1996) but, as pathogenic mycobacteria have
developed evasion strategies to inhibit the production of NO (Elks
et al., 2014; Queval et al., 2016; Bhat et al., 2017), the NO levels
naturally induced in Mtb-infected macrophages seem to be
insufficient for lysing mycobacteria (Jung et al., 2013). Thus, the
additional production of Nos caused by HKLm prior to infection
likely potentiates the intracellular killing mechanisms. The beneficial
effects of increased NO in neutrophils (Elks et al., 2013) as well as in
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macrophages (Cambier et al., 2014) during early M. marinum
infection have previously been demonstrated in zebrafish larvae.
Cambier and colleagues showed that virulentmycobacteria avoidNO-
mediated intracellular killing during the early phase of infection by
hiding their TLR ligands under a phthiocerol dimycoceroserate coat
(Cambier et al., 2014). Co-infecting zebrafish larvaewithM.marinum
and Staphylococcus aureus or Pseudomonas aeruginosa leads to
attenuation of mycobacterial infection (Cambier et al., 2014). Also,
co-injection of liveM.marinumwith heat-killedM.marinum orwith a
mutant with exposed TLR ligands caused similar attenuation
(Cambier et al., 2014). It is likely that at least part of the protective
effects caused by HKLm in the adult zebrafish are mediated through
TLR ligands. The component analysis of HKLm suggested that
nucleotideswere important forHKLm-mediated protection againstM.
marinum. TLR9, which recognizes double-stranded DNA and leads
to the induction of Nos2 (Ito et al., 2005), is a receptor potentially
responsible for the protection. However, detailed analysis of the
signaling pathways activated by HKLm treatment was beyond the
scope of this study.
Tnfα is also known to mediate intracellular killing of
mycobacteria by macrophages (Roca and Ramakrishnan, 2013)
and optimal levels of this cytokine have been proposed to lead to
early clearance of TB in humans (Cobat et al., 2015). Studies in
zebrafish larvae have shown that high Tnfα levels alongside high
ROS levels within macrophages, during the early days of
mycobacterial infection, is bactericidal (Roca and Ramakrishnan,
2013). Sod2 is an enzyme that acts through neutralization of
mitochondrial ROS (Pias et al., 2003). Its downregulation by
HKLm should thus cause an increase in mitochondrial ROS, the
high levels of which have been shown to enhance intracellular
killing mechanisms within macrophages (reviewed in Hall et al.,
2014). Recently, in a human population study, a genetic variant
leading to reduced activity of Sod2 was found to be associated with
increased resistance to leprosy, a disease caused byMycobacterium
leprae (Ramos et al., 2016). Therefore, a likely mechanism of
clearing the mycobacterial infection by HKLm priming in the adult
zebrafish model is mediated through increased Tnfα and decreased
Sod2 production that together lead to higher, mycobacteriocidal,
levels of ROS within macrophages.
Roca and Ramakrishnan also showed that, when the expression
of Tnfα is endogenously high, continuously high ROS levels after
the first days of infection lead to excessive inflammation, necrosis
and exacerbation of the disease (Roca and Ramakrishnan, 2013).
This probably also explains the increased mortality with the higher
HKLm dose. With a single small dose of HKLm used in our study,
the effects of the treatment were undoubtedly positive, but it must be
kept in mind that excessive or prolonged induction of Tnfα and ROS
can also have detrimental effects. The dosage of treatment as well as
the genotype of the host, affecting the baseline production of
inflammatory cytokines, will also need to be carefully considered in
the development of host-directed immunomodulatory treatments.
Based on the gene expression data, the changes in the innate
immunity induced by HKLm in the adult zebrafish seem to be
mediated through an increased number and activation of M1-type
macrophages. Recent research on the metabolism of different innate
immune cells has shown that M1 macrophages have decreased
oxygen consumption, and increased glycolysis and lactate
production (Cheng et al., 2014). In our experiments, the oxygen
consumption of mouse macrophages was significantly decreased by
HKLm priming (Fig. 5I), providing a further piece of evidence of
M1 macrophages playing a central role in HKLm-mediated
protection against mycobacterial infection. The result also implies
that the types of activation caused by HKLm in the zebrafish are
similar to those induced in mammalian macrophages.
Overall, we show that protective and even sterilizing immune
responses can be induced in the zebrafish model for TB by priming
with HKLm. The response is induced even in the absence of
adaptive immunity and is accompanied by the increase in the
number of macrophages, the induction of tnfα and nos2b, and the
downregulation of sod2, likely leading to increased production of
radical nitrogen and oxygen species and enhanced intracellular
killing of mycobacteria. Based on our results, it seems that the type
of activation induced by HKLm treatment is only effective when
delivered at an early enough time point prior to exposure to
pathogenic mycobacteria. The model provides a platform in which
both innate and adaptive mechanisms leading to sterilization of
mycobacterial infection can be reliably studied. Such knowledge
will contribute to the development of new vaccination strategies as
well as host-directed therapies aimed at prevention of transmission
and sterilizing treatment of TB disease.
MATERIALS AND METHODS
Zebrafish lines and housing
Adult 5- to 10-month-old male and female AB wild-type zebrafish (Danio
rerio) and rag1−/− (hu1999) mutant zebrafish (from Zebrafish International
Resource Center, University of Oregon, OR, USA) were used in the
experiments. The fish were housed in flow-through water-circulation
systems with a 14 h/10 h light/dark cycle.
Ethics statement
All experiments were conducted according to the Finnish Act on Animal
Experimentation (62/2006) and the Act on the Protection of Animals
Used for Scientific or Educational Purposes (497/2013). ELLA
(Eläinkoelautakunta; the National Animal Experiment Board in Finland
under the Regional State Administrative Agency for Southern Finland)
approved the Tampere zebrafish facility and the animal experiments carried
out in this project under the licenses ESAVI/6407/04.10.03/2012, ESAVI/
8245/04.10.07/2015 and ESAVI/10079/04.10.06/2015.
Experimental M. marinum infections
Mycobacterium marinum (ATCC 927) was first pre-cultured on
Middlebrook 7H10 plates with OADC enrichment (Fisher Scientific, NH,
USA) at 29°C for 1 week. After plate culturing,M. marinumwas transferred
into Middlebrook 7H9 medium with ADC enrichment (Fisher Scientific,
NH, USA) with 0.2% Tween-80 (Sigma-Aldrich, MO, USA), cultured for
3-4 days, diluted 1:10 and cultured for a further 2 days until OD600 nm
reached 0.460-0.650. For adult zebrafish infections, M. marinum was first
harvested by centrifuging for 3 min at 10,000 g and was then resuspended
and diluted in sterile 1× PBSwith 0.3 mg/ml of Phenol Red (Sigma-Aldrich,
MO, USA). A total of 5 µl of the suspension (33±19 cfu/fish) was injected
i.p. with an Omnican 100 30 G insulin needle (Braun, Melsungen,
Germany) under 0.02% 3-aminobenzoic acid ethyl ester (pH 7.0) (Sigma-
Aldrich, MO, USA) anesthesia. Infection doses were verified by plating 5 µl
of the injection suspension on a 7H10 plate.
For larval infections, the M. marinum pTEC15 strain was used. This
in-house-made M. marinum wasabi-fluorescent strain was made by
transforming a pTEC15 plasmid (Addgene plasmid #30174, deposited
by Lalita Ramakrishnan; Takaki et al., 2013) into the M. marinum ATCC
927 strain by electroporation. For larval infections, theM. marinum pTEC15
strain was cultured for 4-5 days in supplemented 7H9 medium with 75 µg/
ml hygromycin (Merck, Darmstadt, Germany), diluted 1:10, cultured for
3 days until the OD600 nm was 0.407-0.537 and harvested for infection by
centrifugation.
Zebrafish larval infection experiments
To study the effect of HKLm priming in zebrafish larvae, 1 nl of HKLm
(240 cfu) or PBS control were injected into the caudal vein at 1 dpf under
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0.0045% 1-phenyl-2-thiourea (Sigma-Aldrich, MO, USA) anesthesia. At
2 dpf the larvae were infected with 1 nl ofM. marinum (39±13 cfu) into the
blood circulation valley, transferred to fresh E3medium and kept at 29°C. At
8 dpi, larvae were collected for DNA extraction with TRI Reagent (Fisher
Scientific, NH, USA). DNA extraction was performed according to the
manufacturer’s instructions, after which M. marinum-specific qPCR was
used to quantify mycobacteria.
For the quantification of pTEC15 fluorescence, 1-dpf wild-type AB
embryos were dechorionated and kept in E3 medium with 0.0045% 1-
phenyl-2-thiourea (Sigma-Aldrich, MO, USA) at 29°C to prevent
pigmentation. A total of 1 nl of wasabi-fluorescent M. marinum
suspension (39±16 cfu) with 0.6 mg/ml of Phenol Red (Sigma-Aldrich,
MO, USA) and 490 cfu of HKLm were microinjected into the blood
circulation valley at 2 dpf with a glass microcapillary.M. marinum infection
doses were verified by plating the injection doses on a 7H10 agar plate. After
infection, the larvae were kept in E3 medium with 0.0045% 1-phenyl-2-
thiourea (Sigma-Aldrich, MO, USA) on 24-well plates at 29°C.
At 7 dpi, larvae were anesthetized with 0.02% 3-aminobenzoic acid ethyl
ester (pH 7.0) (Sigma-Aldrich, MO, USA). The larvae were embedded on
their side in 1% low-melt agarose in E3 medium on black 96-proxiplates
(Perkin-Elmer, MA, USA). Extra E3 medium with the anesthetic was added
on top of the solidified low-melt agarose to prevent the larvae from drying.
The wasabi-fluorescent signal was measured three times using the EnVision
plate reader (Perkin-Elmer, MA, USA) scanning program. The scan
measurement was carried out on five horizontal and five vertical dots
0.5 mm apart from 6.5 mm height with 100% excitation at 493 nm, 509 nm
emission and 500 flashes per point. The fluorescent signals of individual
zebrafish larvae were normalized with the average signal from healthy non-
infected larvae.
Preparation of heat-killed bacteria and priming injections
For the preparation of heat-killed bacteria, L. monocytogenes (10403S),
E. coli (ATCC 25922), S. aureus (ATCC 29213), S. typhimurium (ATCC
14028) and S. iniae (ATCC 29178) were inoculated from glycerol stocks or
blood agar plates and cultured in brain heart broth (BHB) (Sigma-Aldrich,
MO, USA) at 37°C until the OD600 nm reached 0.9-1.0. Bacterial
suspensions were plated on LB agar plates to verify bacterial
concentrations. To heat-kill bacteria, the bacterial suspensions were
autoclaved in BHB at 120°C for 20 min and the sterility was confirmed
by plating on LB plates after autoclaving. Injection doses of heat-killed
bacteria for adult zebrafish were 0.5×107-1×107 cfu. Injection doses for
other priming agents were 13.5 µg/fish for LPS (Sigma-Aldrich, MO,
USA), paclitaxel (Sigma-Aldrich, MO, USA) and zymosan (Sigma-
Aldrich, MO, USA), and 4.5 µg/fish for muramyl-dipeptide (Sigma-
Aldrich, MO, USA). Priming i.p. injections (5 µl) were injected with an
Omnican 100 30 G insulin needle (Braun, Melsungen, Germany) under
0.02% 3-aminobenzoic acid ethyl ester (pH 7.0) anesthesia.
DNase, RNase and proteinase K treatment of HKLm
DNase and RNase treatments were performed for autoclaved L.
monocytogenes in BHB medium. Heat-killed bacterial suspension was
incubated with 10 µg/ml of RNase A (Thermo Fisher Scientific, NH, USA)
at 37°C for 18 h. After RNase treatment, the suspension was treated with
83 U/ml DNase I (Thermo Fisher Scientific, NH, USA) according to the
manufacturer’s instructions. Accordingly, HKLmwas treated with 10 µg/ml
of proteinase K (Thermo Fisher Scientific, NH, USA) at 37°C for 18 h and
inactivated at 70°C for 15 min before injections.
RNA and DNA extractions from zebrafish samples
For RNA and DNA extractions, adult zebrafish were first euthanized with an
overdose of 3-aminobenzoic acid ethyl ester anesthetic and then internal
organs were collected from the body cavity. Organs were homogenized in
TRI Reagent (Thermo Fisher Scientific, NH, USA) with ceramic beads
using the PowerLyzer24 (Mobio, CA, USA) bead beater at 3200 rpm for
3×40 s. Samples were cooled on ice between the cycles. After
homogenization, samples were sonicated for 9 min and the RNA and
DNA were extracted according to the manufacturer’s instructions.
Gene expression studies and quantifyingmycobacterial loads by
qPCR
Prior to qPCR analysis, RNA was treated with DNase I (Thermo Fisher
Scientific, NH, USA) to remove possible traces of genomic DNA according
to the manufacturer’s instructions. After DNase treatment, RNAwas reverse
transcribed into cDNA with a Reverse Transcription kit (Fluidigm, CA,
USA) according to the manufacturer’s instructions. Gene expression was
measured by using SsoFast EvaGreen Supermix with Low ROX qPCR kit
(Bio-Rad, CA, USA) with the CFX96 qPCR system (Bio-Rad, CA, USA).
Zebrafish geneswere normalizedwith expressed repetitive element loopern4
(Vanhauwaert et al., 2014) and compared with the average induction of
pooled baseline sample of healthy non-infected zebrafish. Results were
analyzed using the ΔCt method and are shown as fold induction.
Mycobacterial loads were measured with the SensiFAST SYBRNo-ROX
qPCR kit (Bioline, London, UK) from genomic DNA according to the
manufacturer’s instructions. Each bacterial quantification qPCR run
included standard curve of known amounts of M. marinum DNA. Primer
sequences and gene association numbers are shown in Table 1.
Table 1. Primer pairs used in qPCR
Name Gene Primer sequences (5′-3′)
ifnγ1-2 ZDB-GENE-040629-1 F: GGGCGATCAAGGAAAACGACCC
R: TAGCCTGCCGTCTCTTGCGT
ifnγ1-1 ZDB-GENE-060210-1 F: CCAGGATATTCACTCAGTCAAGGC
R: TGTGGAGGCCCGATAATACACC
loopern4 Expressed repetitive elements F: TGAGCTGAAACTTTACAGACACAT
R: AGACTTTGGTGTCTCCAGAATG
nos2b ZDB-GENE-080916-1 F: TCACCACAAAAGAGCTGGAATTCGG
R: ACGCGCATCAAACAACTGCAAA
sod2 ZDB-GENE-030131-7742 F: GGCCATAAAGCGTGACTTTG
R: GCTGCAATCCTCAATCTTCC
tnf ZDB-GENE-050317-1 F: GGGCAATCAACAAGATGGAAG
R: GCAGCTGATGTGCAAAGACAC
arg1 ZDB-GENE-040724-181 F: TGGGAATAATAGGCGCTCCGTTC
R: TCCTTCACCACACAACCTTGC
mpeg1 ZDB-GENE-081105-5 F: CTTCTGTTTCAGCATCAGCCG
R: ATAAAGCTCCTCCGTGGCTC
mpx ZDB-GENE-030131-9460 F: AACACTGAACTAGCCCGCAA
R: CAACCTATCGCCATCTCGGA
16S–23S ITS Locus AB548718 for M. marinum quantification F: CACCACGAGAAACACTCCAA
R: ACATCCCGAAACCAACAGAG
F, forward; R, reverse.
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Measurement of oxygen consumption in HKLm-primed
RAW264.7 cells
To measure oxygen consumption, RAW264.7 cells (ATCC TIB-71) were
cultured in Dulbecco’s modified Eagle’s medium with 4.5 g/l D-glucose
and L-glutamine (Gibco, Thermo Fisher Scientific, NH, USA)
supplemented with 10% of heat-inactivated fetal bovine serum (Gibco,
Thermo Fisher Scientific, NH, USA) and 100 U/ml penicillin-streptomycin
(Thermo Fisher Scientific, NH, USA) at 37°C with 5% CO2. The cells were
primed either with 50 ng/ml of LPS or HKLm to correspond to an MOI of
530. At 19-24 h later the media was changed to fresh media including
priming agents. A minimum of 30 min later the oxygen consumption from
5 million cells was measured at 37°C in their culture media using a Clark
electrode (Hansatech, UK). Mitochondrial respiration was measured as the
total minus the background oxygen consumption; the latter being
determined by exposing the cell suspension to 150-270 nM of antimycin
A (Sigma-Aldrich, MO, USA), a potent inhibitor of the respiratory chain
complex III.
Statistical analyses
GraphPad Prism software (5.02) was used to carry out statistical analysis. A
non-parametric two-tailed Mann–Whitney test was used to compare
differences between experimental groups. Bonferroni’s post-test was
used to correct P-values for multiple comparisons. P-values smaller than
0.05 were considered as significant. The sample sizes for experimental fish
groups were calculated with power and sample size program (version 3.1.2)
by using data from our preliminary studies (Dupont and Plummer, 1998).
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Foundation (M.P.), Emil Aaltonen Foundation (M.M.H.), Jane and Aatos Erkko
Foundation (M.R.) and AFM-Téléthon (#17424, E.D.)
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